Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-20

Clinical Trial Update: Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia [Phase 3]

View source ↗

Summary

Completed Phase 3 trial evaluating metabolic parameters of sertindole in patients with schizophrenia; the document is an update, but specific results are not pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sertindole (sertindole)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED